Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Syntegra and the Institute for Health Metrics Expand Strategic Partnership to Bring Privacy-Guaranteed Healthcare Data to Life Sciences

Syntegra, a leader in synthetic data generation, and the Institute for Health Metrics (IHM), the not-for-profit hospital data collaborative, announced an expanded partnership to enable easier and faster access to millions of privacy-guaranteed electronic health records for life sciences companies.

This strategic partnership combines the privacy-preserving capabilities of Syntegra’s synthetic data engine with IHM’s vast data repository to provide access to high-fidelity, patient-level data that would not otherwise be available. Organizations can access more granular data, and share it more broadly without the privacy risk of protected health information. This unprecedented level of data access enables the life sciences industry to drive innovation and accelerate the development of new treatments for patients.

Recommended AI News: HUB International Embeds Auto Insurance into Wayne Reaves Auto Dealer Management Software

The EHR data is representative of 7 million patients from health systems across the US, spans a five-year time period, and includes a comprehensive and diverse range of patient demographics and therapeutic areas. Notably, this data also includes social determinants of health variables (such as housing and food insecurity), as well as date-time stamps.

Pharma organizations can leverage this synthetic data offering to quickly understand the data and improve the design of their RWE and HEOR studies with fewer barriers. They can then complement the real data with synthetic to expand rare or underrepresented populations for deeper analyses, leveraging Syntegra’s customization capabilities.

Related Posts
1 of 33,477

Recommended AI News: New Slack Innovations and Salesforce Customer 360 Integrations Unlock Team Productivity, Adding Value to the Digital HQ

“Our partnership with Syntegra combines IHM’s clinical data with Syntegra’s world class synthetic data fabrication technology, enabling many more users with the insight available from protected health information without the risk of mishandling PHI,” said Tom Gaither, COO of IHM. “We look forward to working with the Syntegra team to set the standard for realistic and risk-free clinical data at scale.”

“We’re thrilled to be expanding our partnership with IHM,” said Michael D. Lesh, SM MD FACC, Syntegra founder and CEO. “Together, we’re opening up access to millions of patient records with a level of privacy protection unlike ever before, further enabling innovation in healthcare.”

Recommended AI News: Wiha Tools USA Adopts New Salsify Connector to Amazon A+ API

[To share your insights with us, please write to sghosh@martechseries.com]

Comments are closed.